health

Alternative approaches to animal testing

Alternative approaches to animal testing

In 1959, The Principles of Humane Experimental Technique was published by Russell and Burch, introducing the 3Rs concept (replacement, reduction, and refinement) regarding animal use in the scientific community. Just over 60 years later, it is timely to review progress to date and the future outlook regarding alternative approaches to animal testing.

A Scientist's Opinion : interview with Prof. Maurice Whelan about Animal testing

A scientist’s opinion : Interview with Professor Maurice Whelan about animal testing

Animal testing, a scientist’s opinion Interview with Maurice Whelan, head of EURL ECVAM (European Union Reference Laboratory for alternatives to animal testing (EURL ECVAM) at the JRC (Joint Research Centre of the European Comission) in Ispra, Italy. How do you think progress is going on reducing animal use for scientific purposes, and what is the ...

A Scientist's Opinion : interview with Pierfranco Conte about Animal testing

A scientist’s opinion : Interview with Professor PierFranco Conte about animal testing

Animal testing, a scientist’s opinion Interview with Professor PierFranco Conte, Full Professor of Oncology at the University of Padova and Director of the Division of Medical Oncology 2 at the Istituto Oncologico Veneto in Padova. In your opinion, why is animal use for scientific purposes still so common place? Are animal models still essential for ...

A Scientist's Opinion : interview with Dr Jason Johnson about Animal testing

A scientist’s opinion : Interview with Dr Jason Johnson about animal testing

Animal testing, a scientist’s opinion Interview with Dr Jason Johnson, British Heart Foundation Senior Research Fellow, Associate Professor of Cardiovascular Pathology, and leads the Laboratory of Cardiovascular Pathology at Bristol Medical School, University of Bristol. As a scientist, in general do you find that the 3Rs concept is something that is routinely thought of when ...

A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research

A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research

Re-engineering pharmaceutical research, a scientist’s opinion Interview with Aroon Hingorani, Professor of Genetic Epidemiology at University College London. Could you speculate what you think are the biggest causes of drug failure? It is well recognised that the number one cause for drug failure is a lack of efficacy of the drug in the intended indication, ...

A scientist’s opinion : Interview with Dr Denis Lacombe about re-engineering pharmaceutical research

A scientist’s opinion : Interview with Dr Denis Lacombe about re-engineering pharmaceutical research

Re-engineering pharmaceutical research, a scientist’s opinion Interview with Dr Denis Lacombe, Director General of the European Organisation for Research and Treatment of Cancer (EORTC). Can you tell me a bit about the European Organisation for Research and Treatment of Cancer (EORTC)? We are a non-governmental, not-for-profit organisation established for 60 years, focusing on survival and ...

A scientist’s opinion : Interview with Dr Síle Lane about re-engineering pharmaceutical research

A scientist’s opinion : Interview with Dr Síle Lane about re-engineering pharmaceutical research

Re-engineering pharmaceutical research, a scientist’s opinion Interview with Dr Síle Lane, head of international campaigns and policy at Sense About Science. Undisclosed clinical trial results are unfortunately common - how does this impact progression in research and treatment? When results from clinical trials aren’t published it means the same research can get repeated unnecessarily. This ...

EU Project PhilHumans ESMH

EU Project : PhilHumans

PhilHumans : The goal of the PhilHumans (Personal Health Interfaces Leveraging Human-MAchine Natural interactionS) project is to train a next generation of young researchers in innovative Artificial Intelligence (AI) and establish user interaction with their personal health devices in an advanced and intuitive way. PhilHumans will investigate cutting-edge AI methods for human-machine interaction in the ...

EU project Clarify ESMH

EU Project : CLARIFY

CLARIFY : There were 17 million new cases of cancer diagnosed worldwide in 2018. Survival rates of cancer patients were rather poor until recent decades, when diagnostic techniques have been improved and novel therapeutic options have been developed. It is estimated that more than 50% of adult patients diagnosed with cancer live at least 5 ...

A scientist’s opinion Interview with Renate Heinisch about new technologies in medicine

A scientist’s opinion : Interview with Renate Heinisch about new technologies in medicine

New technologies in medicine, a scientist’s opinion Interview with Renate Heinisch, pharmacist, former vice-chair of Science and Technology Options Assessment (STOA) panel and now member of the European Economic and Social Committee New technologies are going to deeply affect healthcare. Will citizens be ready? We must consider that scientific and technological innovations accompanied all of ...